January 2, 2018 / 12:11 PM / 19 days ago

BRIEF-Neximmune Raises $23 Mln

Jan 2 (Reuters) -

* NEXIMMUNE SAYS RAISES $23 MILLION TO ADVANCE ENDOGENOUS CELLULAR IMMUNOTHERAPY INTO CLINICAL DEVELOPMENT Source text for Eikon:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below